Timing, duration, and severity of hyponatremia following pediatric brain tumor surgery*

Jennifer S Belzer1, Cydni N Williams, Jay Riva-Cambrin

  • 11Department of Pediatrics, University of Utah, Salt Lake City, UT. 2Department of Neurosurgery, University of Utah, Salt Lake City, UT. 3Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT.

Insights

Hyponatremia occurred in over half of pediatric patients after intracranial tumor surgery, with severe cases requiring prolonged monitoring. Young children with hydrocephalus face a higher risk of severe hyponatremia.

Area of Science:

  • Pediatric Neurosurgery
  • Endocrinology
  • Critical Care Medicine

Background:

  • Serum sodium changes are a concern in pediatric neurosurgery.
  • Understanding the time course and severity of hyponatremia is crucial for patient management.
  • Intracranial tumor surgery presents unique challenges for fluid and electrolyte balance.

Purpose of the Study:

  • To characterize the temporal patterns, variability, and magnitude of serum sodium alterations in children post-intracranial tumor surgery.
  • To identify risk factors associated with severe hyponatremia in this pediatric population.

Main Methods:

  • Retrospective cohort study of 319 children (0-19 years) undergoing initial intracranial tumor surgery.
  • Patients categorized into severe hyponatremia (≤130 mEq/L), mild hyponatremia (131-135 mEq/L), and normal sodium (>135 mEq/L) groups.
  • Analysis of serum sodium levels, timing of changes, and risk factors including hydrocephalus and age.

Main Results:

  • Over half of the patients developed hyponatremia (43% mild, 12% severe).
  • Sodium levels decreased post-surgery in all groups, with the most significant decline in severe hyponatremia cases.
  • Severe hyponatremia often developed later (median 1.6 days after mild hyponatremia) and persisted longer; obstructive hydrocephalus and age <3.5 years were key risk factors.

Conclusions:

  • Hyponatremia is common following pediatric intracranial tumor surgery, particularly in young children with hydrocephalus.
  • Patients with severe hyponatremia require vigilant, extended monitoring due to the risk of recurrent sodium fluctuations.
  • Further research is needed to optimize monitoring and treatment strategies for severe hyponatremia in this cohort.
Abstract

Related Concept Videos

Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
20
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
30
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
788
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554